HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Blood oxidative stress markers and Plasmodium falciparum malaria in non-immune African children.

Abstract
Converging in vitro evidence and clinical data indicate that oxidative stress may play important roles in Plasmodium falciparum malaria, notably in the pathogenesis of severe anaemia. However, oxidative modifications of the red blood cell (RBC)-membrane by 4-hydroxynonenal (4-HNE) and haemoglobin-binding, previously hypothesized to contribute mechanistically to the pathogenesis of clinical malaria, have not yet been tested for clinical significance. In 349 non-immune Mozambican newborns recruited in a double-blind placebo-controlled chemoprophylaxis trial, oxidative markers including 4-HNE-conjugates and membrane-bound haemoglobin were longitudinally assessed from 2·5 to 24 months of age, at first acute malaria episode and in convalescence. During acute malaria, 4-HNE-conjugates were shown to increase significantly in parasitized and non-parasitized RBCs. In parallel, advanced oxidation protein products (AOPP) rose in plasma. 4-HNE-conjugates correlated with AOPP and established plasma but not with RBC oxidative markers. High individual levels of 4-HNE-conjugates were predictive for increased malaria incidence rates in children until 2 years of life and elevated 4-HNE-conjugates in convalescence accompanied sustained anaemia after a malaria episode, indicating 4-HNE-conjugates as a novel patho-mechanistic factor in malaria. A second oxidative marker, haemoglobin binding to RBC-membranes, hypothesized to induce clearing of RBCs from circulation, was predictive for lower malaria incidence rates. Further studies will show whether or not higher membrane-haemoglobin values at the first malaria episode may provide protection against malaria.
AuthorsRuth Aguilar, Tiziana Marrocco, Oleksii A Skorokhod, Arnoldo Barbosa, Augusto Nhabomba, Maria N Manaca, Caterina Guinovart, Llorenç Quintó, Paolo Arese, Pedro L Alonso, Carlota Dobaño, Evelin Schwarzer
JournalBritish journal of haematology (Br J Haematol) Vol. 164 Issue 3 Pg. 438-50 (Feb 2014) ISSN: 1365-2141 [Electronic] England
PMID24422726 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Copyright© 2013 John Wiley & Sons Ltd.
Chemical References
  • Aldehydes
  • Antigens, Protozoan
  • Antimalarials
  • Artemisinins
  • Biomarkers
  • sulfadoxine-pyrimethamine-artesunate
  • Sulfadoxine
  • 4-hydroxy-2-nonenal
  • Pyrimethamine
Topics
  • Aldehydes (blood)
  • Anemia (blood, immunology, microbiology)
  • Antigens, Protozoan (immunology)
  • Antimalarials (therapeutic use)
  • Artemisinins (therapeutic use)
  • Biomarkers (blood)
  • Child, Preschool
  • Double-Blind Method
  • Endemic Diseases
  • Erythrocytes (immunology, metabolism, parasitology)
  • Humans
  • Infant
  • Malaria, Falciparum (blood, epidemiology, immunology, prevention & control)
  • Mozambique (epidemiology)
  • Oxidative Stress (physiology)
  • Pyrimethamine (therapeutic use)
  • Sulfadoxine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: